2nd Annual Acute Lymphoblastic Leukemia Fellows Scholar Program

 

Date of Meeting: November 2-3, 2024

The 2nd Annual Acute Lymphoblastic Leukemia Fellows Scholar Program (ALLFSP) was an intensive multi-day course designed for adult and pediatric hematology/oncology fellows to expand their education and understanding of the complex and evolving therapeutic space of ALL. The primary objective for the second installment of this program was to provide fellows with a thorough review of the current management for ALL across diverse patient populations. Additionally, the agenda fostered discussions on the future trajectory of therapy, potential areas for refinement, and the unresolved questions that are driving research.

Sessions

Session 1
Title: Advances in ALL Treatment: The State of the Science in 2024
Faculty: Emily K. Curran, MD

Session 2
Title: ALL Treatment in Pediatrics
Faculty: Luke Maese, DO

Session 3
Title: ALL Treatment in AYAs
Faculty: Adam DuVall, MD

Session 4
Title: ALL Treatment in Older Adults
Faculty: Marlise Luskin, MD, MSCE

Session 5
Title: Addressing Health Disparities, Survivorship, and Quality of Life
Faculty: Julie Wolfson, MD, MSHS

Session 6
Title: Using ASNase Formulations in ALL and Addressing Hypersensitivity
Faculty: Emily K. Curran, MD

Session 7
Title: Managing ASNase Toxicities
Faculty: Luke Maese, DO

Session 8
Title: Therapy Selection in Ph+ ALL—Pediatric vs Adult Treatment
Faculty: Julie Wolfson, MD, MSHS and Marlise Luskin, MD, MSCE

Session 9
Title: R/R ALL and the Role of Transplantation
Faculty: Adam DuVall, MD

This activity is supported by an independent medical education grant from Jazz Pharmaceuticals.

Presented by Creative Educational Concepts.